Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. - sprookjes - yvandenbroek - TriplyDB

Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.

Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.

http://www.wikidata.org/entity/Q35250965

about

A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation Molecular processes that handle -- and mishandle -- dietary lipids Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans Pathophysiology of heparan sulphate: many diseases, few drugs Human genetic disorders and knockout mice deficient in glycosaminoglycan Lipoproteins in Drosophila melanogaster--assembly, function, and influence on tissue lipid composition Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X Conversion of low density lipoprotein-associated phosphatidylcholine to triacylglycerol by primary hepatocytes The effect of old age on apolipoprotein E and its receptors in rat liver MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Altered heparan sulfate structure in mice with deleted NDST3 gene function.Insulin-dependent diabetes mellitus in mice does not alter liver heparan sulfate SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus.Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice.Syndecan-1 is required to maintain intradermal fat and prevent cold stress.Low density lipoprotein receptor-related protein 1 dependent endosomal trapping and recycling of apolipoprotein E.Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content Impaired LDL receptor-related protein 1 translocation correlates with improved dyslipidemia and atherosclerosis in apoE-deficient mice.Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter.Reducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling.The dominating role of N-deacetylase/N-sulfotransferase 1 in forming domain structures in heparan sulfate Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects Heparan sulfate proteoglycans.microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis.Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans.Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E Novel method for reducing plasma cholesterol: a ligand replacement therapy.Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemia.Role of Deacetylase Activity of N-Deacetylase/N-Sulfotransferase 1 in Forming N-Sulfated Domain in Heparan Sulfate The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.Glucuronic acid epimerase is associated with plasma triglyceride and high-density lipoprotein cholesterol levels in Turks.Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors.Complexity of microRNA function and the role of isomiRs in lipid homeostasis.

P2860

Q24322895-F8F1FC12-29A8-4605-8B88-9C42C9096CEB Q24642118-DD197CC3-D3A6-4898-BEF6-188A652D0909 Q24647376-CCDFFB59-3292-4280-9C81-6E966D3B9E7B Q26766645-CBEAC564-9821-46EF-B325-DFED3644DF75 Q26774776-CBE30F08-BC59-4AB2-A0EA-D4CF9836B98C Q26823840-CD540EBC-83FF-4A4E-8C0F-C9D18C02B2EE Q26995332-843D13C0-6BA7-450B-9906-7EE1FFC8102D Q27332377-0225DAC0-9DD7-4736-9E8E-5EA42C1A034C Q28475714-2CBC5B4C-7E10-4AA4-BE96-A3E73396C612 Q28506881-03BEAD70-66E5-465E-BF82-20382F410B5C Q28574743-5FD4CECA-DCD2-4E4F-90CE-1B5E630EB2F6 Q29615034-20441C89-AD70-4970-96AC-77225D4647FB Q30488977-4139950A-A0EC-48AD-8AE9-D3CF90B3865A Q33541795-840F2E48-3188-49DA-A844-D3973B6FF682 Q33560966-2ED0D87D-9283-4B4D-BF7F-7D7D6C2413E2 Q33581252-322CD73A-8205-43A5-9C55-6A93E27AC08D Q33750290-2EBB665C-7B13-49A6-AAE5-3B7964F0ED54 Q33869288-B7205452-4A81-4556-B3C0-118561382D8E Q34015240-D0078397-AF4B-4CA5-9510-5B8CA42212B9 Q34125060-FA5B1725-DC2A-4EB8-916C-CAF3C5ED1D89 Q34143697-834B3483-3304-46E0-A57D-174C40A9108E Q34305393-B6454048-F776-4C6F-A567-77DCB2234643 Q34348377-90EAB8D2-7337-4294-BD11-D92C4941AD6C Q34419003-A3448CEE-BF66-47E5-A678-958E4C3996F9 Q34625670-99B7C802-4A6D-46C1-89D3-DCD770EADCAE Q35011046-972472A1-0C24-4E0F-AF67-B79FCB747D65 Q35053168-D17517A3-38A7-4C7A-BDDD-9BDEA5DF6434 Q35059448-20036B81-5F4B-415B-A06F-19F4DEC5E981 Q35116623-A2366277-7BC9-47F1-86D5-C62D4C49B6DC Q35120945-DDE221E2-DFE1-4B9E-A530-1354189114E8 Q35153978-ED801025-6081-45F9-89E6-1F8415C702AF Q35558371-23E03C1B-B922-4195-B283-FE9B0304E2DB Q35631767-DB5AF224-B344-4B94-B2B3-87E76A1719C6 Q35936964-758DA28C-DBC7-471E-A597-266B3CB6CC9E Q35953176-759D5816-91ED-4EE7-B038-0DED95AB3418 Q35955763-D63B9FEA-4120-4841-BDE7-0939CB87B131 Q36513995-AD02FD00-47FF-4BFE-9798-A1440F3770E4 Q36577724-B586267B-6DDE-4B02-A705-DF47B921536E Q36745042-8249659C-2B97-4A54-BDE7-43667176898C Q36754775-792B75B1-18C7-47E3-9993-66B49A74EB24

P2860

Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.

http://www.wikidata.org/entity/Q35250965

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Liver heparan sulfate proteogl ...... f LDL receptor family members.

@ast

Liver heparan sulfate proteogl ...... f LDL receptor family members.

@en

type

label

Liver heparan sulfate proteogl ...... f LDL receptor family members.

@ast

Liver heparan sulfate proteogl ...... f LDL receptor family members.

@en

prefLabel

Liver heparan sulfate proteogl ...... f LDL receptor family members.

@ast

Liver heparan sulfate proteogl ...... f LDL receptor family members.

@en

P1433

Q35250965-DF79ED73-1EE6-405F-AABF-405884D01BC6

P1476

Q35250965-6CE57FDA-24BE-42F9-9077-56F9EE99CCCF

P2093

Q35250965-051F87A5-265C-45D9-941B-84243FD2B3DF

Q35250965-11B08AC3-CA3B-4047-A1FC-CF0CCE9F0F2D

Q35250965-8775AF6B-3E97-4FFF-AA66-ECFF11D0A6FF

Q35250965-95C04D36-9717-4CF1-B38B-A8B434C242DD

Q35250965-BA212BCB-8356-4536-99B8-D244F6EB0A6F

P2860

Q35250965-0C328A61-3D01-4A6D-8D31-60F4ABA04143

Q35250965-0E520220-AB12-4DD5-93F6-1317AE28F304

Q35250965-14DA2940-FCD9-4FE0-9F14-5477FF1E55CC

Q35250965-17A664AF-E8E0-4892-A35D-5EFD2B08E07A

Q35250965-197E3B38-6026-495A-91CF-FFF641A9452D

Q35250965-1A975987-C410-461B-9608-6A9ED1F90E5E

Q35250965-1E7241B2-C960-4F92-A810-0441224B1856

Q35250965-2256688C-50D7-4C1A-8C52-78A502B60616

Q35250965-24992560-4EF8-415D-ACE1-197C274BB1D5

Q35250965-28553B44-B7B9-4D6A-A713-CB363E004C51

P304

Q35250965-82BF7EFD-80EA-4D1B-A02B-95E0297CB561

P31

Q35250965-36870FB7-6777-4B44-AEA7-8271057691EE

P356

Q35250965-3F1388D2-41D8-4C28-AD2D-0E5704DFE7C4

P407

Q35250965-FB614A33-01D9-4C59-B252-FEFBD54B0797

P433

Q35250965-D8699A63-9E52-4BCA-AA48-E958FA269B48

P478

Q35250965-0B8E7D8C-4FE5-45D0-9CB1-D7AA38B6498D

P50

Q35250965-1ECE6BAF-2307-4C00-95CC-5C310D9015F8

Q35250965-443056A1-AC58-4577-A012-C0F116F233CB

P577

Q35250965-6B82E6EB-46CF-4691-B070-28898A706F1B

P698

Q35250965-7DDF6082-C09E-48FE-8F6E-E548BB6DCE50

P921

Q35250965-99BA2BA7-0BA7-40A5-BB3B-BC34198A4EA8

Q35250965-FE305294-96EE-4861-B9C2-6CDA9CDDAAA3

P932

Q35250965-7BE34D55-0D68-47C6-A0F9-CDC93C529920

P356

P1433

Journal of Clinical Investigation

P1476

Liver heparan sulfate proteogl ...... f LDL receptor family members.

@en

P2093

Jeffrey D Esko

http://www.w3.org/2001/XMLSchema#string

Jennifer M MacArthur

http://www.w3.org/2001/XMLSchema#string

Joseph R Bishop

http://www.w3.org/2001/XMLSchema#string

Kristin I Stanford

http://www.w3.org/2001/XMLSchema#string

Lianchun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion

Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Interaction of the N-terminal domain of apolipoprotein E4 with heparin

An automated multidimensional protein identification technology for shotgun proteomics

Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E

Apoprotein C-III deficiency markedly stimulates triglyceride secretion in vivo: comparison with apoprotein E

Binding of hepatic lipase to heparin. Identification of specific heparin-binding residues in two distinct positive charge clusters

Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme

Mammalian brain morphogenesis and midline axon guidance require heparan sulfate

P304

153-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI29154

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

André Bensadoun

Joseph L Witztum

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17200715

http://www.w3.org/2001/XMLSchema#string

P921

P932

1716206

http://www.w3.org/2001/XMLSchema#string